Innovations in breast cancer imaging: PET for diagnosis and follow-up.

Abstract

Could positron emission tomography (PET), which identifies the higher metabolism of malignant tumors, become the noninvasive test needed to assess the thousands of falsely positive mammograms? Could serial scans be used to evaluate response to chemotherapy? This team examines the data on current and potential uses of PET.